L-Leucyl-L-Leucine Methyl Ester

A 2-amino acid compound with immunomodulatory activity. L-leucyl-L-leucine methyl ester (LLME) is a lysosomotropic agent entering cells via receptor-mediated endocytosis. LLME undergoes a condensation process catalyzed by dipeptidyl peptidase I (DPPI) in lysosomes. Condensation of LLME leads to lysosomal rupture and DNA fragmentation in DPPI-expressing immune cells such as cytotoxic T-cells and natural killer cells. Therefore, this agent may be able to decrease the incidence of graft versus host disease (GVHD) via cytotoxic T-cell depletion. Furthermore, LLME has the potential in augmenting antibody production when used in pretreatment of peripheral blood mononuclear cells (PBMCs), possibly via interfering gene expressions of inflammatory factors. (NCI Thesaurus)

YOU MAY ALSO LIKE

L-Lactate Dehydrogenase A Chain

L-lactate dehydrogenase A chain (332 aa, ~37 kDa) is encoded by the human LDHA gene. This protein is involved in the metabolism…

L-Gossypol

The levo-enantiomer of an orally bioavailable polyphenolic aldehyde, derived primarily from unrefined cottonseed oil, with potential antineoplastic activity. Mimicking the inhibitory BH3…

L-glutamic acid

One of twenty amino acids (molecules that join together to form proteins). L-glutamic acid may help nerve cells send and receive information…

L-Epicatechin

A catechin with the R configuration at C-2 and C-3.

L-Dopachrome Tautomerase

L-dopachrome tautomerase (519 aa, ~59 kDa) is encoded by the human DCT gene. This protein is involved in the biosynthesis of…

L-Cell Glucagon-Like Peptide-Producing Neuroendocrine Tumor

A neuroendocrine tumor that arises from the gastrointestinal tract and produces glucagon-like peptides. Morphologically, it is characterized by the presence of…